Literature DB >> 12093677

Antigenicity of Leishmania braziliensis histone H1 during cutaneous leishmaniasis: localization of antigenic determinants.

Emma Carmelo1, Enrique Martínez, Ana Cristina González, José Enrique Piñero, Manuel E Patarroyo, Antonio Del Castillo, Basilio Valladares.   

Abstract

The humoral immune response against Leishmania braziliensis histone H1 by patients with cutaneous leishmaniasis is described. For this purpose, the protein was purified as a recombinant protein in a prokaryotic expression system and was assayed by enzyme-linked immunosorbent assay (ELISA) with a collection of sera from patients with cutaneous leishmaniasis and Chagas' disease. The assays showed that L. braziliensis histone H1 was recognized by 66% of the serum samples from patients with leishmaniasis and by 40% of the serum samples from patients with Chagas' disease, indicating that it acts as an immunogen during cutaneous leishmaniasis. In order to locate the linear antigenic determinants of this protein, a collection of synthetic peptides covering the L. braziliensis histone H1sequence was tested by ELISA. The experiments showed that the main antigenic determinant is located in the central region of this protein. Our results show that the recombinant L. braziliensis histone H1 is recognized by a significant percentage of serum samples from patients with cutaneous leishmaniasis, but use of this protein as a tool for the diagnosis of cutaneous leishmaniasis is hampered by the cross-reaction with sera from patients with Chagas' disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093677      PMCID: PMC120041          DOI: 10.1128/cdli.9.4.808-811.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  18 in total

Review 1.  Chagas' disease and the autoimmunity hypothesis.

Authors:  F Kierszenbaum
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Cloning and molecular characterization of the cDNA encoding histone H1 from Leishmania braziliensis.

Authors:  E Martínez; M C Thomas; V Alonso; E Carmelo; A C González; A Del Castillo; B Valladares
Journal:  J Parasitol       Date:  2002-02       Impact factor: 1.276

3.  Identification of potentially diagnostic Leishmania braziliensis antigens in human cutaneous leishmaniasis by immunoblot analysis.

Authors:  M E Brito; M G Mendonça; Y M Gomes; M L Jardim; F G Abath
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

4.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.

Authors:  R A Houghten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  The histones of the insect trypanosomatid, Crithidia fasciculata.

Authors:  V G Duschak; J J Cazzulo
Journal:  Biochim Biophys Acta       Date:  1990-09-03

7.  Identification of a histone H1-like gene expressed in Leishmania major.

Authors:  N J Fasel; D C Robyr; J Mauel; T A Glaser
Journal:  Mol Biochem Parasitol       Date:  1993-12       Impact factor: 1.759

8.  Reactivity of autoantibodies in systemic lupus erythematosus with synthetic core histone peptides.

Authors:  S Muller; D Bonnier; M Thiry; M H Van Regenmortel
Journal:  Int Arch Allergy Appl Immunol       Date:  1989

9.  Biochemical and functional characterization of histone H1-like proteins in procyclic Trypanosoma brucei brucei.

Authors:  M Burri; W Schlimme; B Betschart; U Kämpfer; J Schaller; H Hecker
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

10.  The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus.

Authors:  R W Burlingame; M L Boey; G Starkebaum; R L Rubin
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

View more
  7 in total

Review 1.  The genetics of Leishmania virulence.

Authors:  Eugenia Bifeld; Joachim Clos
Journal:  Med Microbiol Immunol       Date:  2015-06-06       Impact factor: 3.402

2.  Identification of novel Leishmania major antigens that elicit IgG2a response in resistant and susceptible mice.

Authors:  Mohammad Reza Mohammadi; Majid Zeinali; Sussan K Ardestani; Amina Kariminia
Journal:  Korean J Parasitol       Date:  2006-03       Impact factor: 1.341

3.  Mechanical performance of collagen gels is dependent on purity, α1/α2 ratio, and telopeptides.

Authors:  Leigh Slyker; Nicole Diamantides; Jongkil Kim; Lawrence J Bonassar
Journal:  J Biomed Mater Res A       Date:  2021-07-08       Impact factor: 4.854

4.  Enhancement of experimental cutaneous leishmaniasis by Leishmania extract: identification of a disease-associated antibody specificity.

Authors:  Virgínia M G Silva; Cíntia F de-Araújo; Isabela C Navarro; Pablo R S Oliveira; Lain Pontes-de-Carvalho
Journal:  BMC Res Notes       Date:  2015-05-14

5.  Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins.

Authors:  Maria Agallou; Evita Athanasiou; Olga Koutsoni; Eleni Dotsika; Evdokia Karagouni
Journal:  Front Immunol       Date:  2014-06-10       Impact factor: 7.561

6.  Vaccination with L. infantum chagasi nucleosomal histones confers protection against new world cutaneous leishmaniasis caused by Leishmania braziliensis.

Authors:  Marcia W Carneiro; Diego M Santos; Kiyoshi F Fukutani; Jorge Clarencio; Jose Carlos Miranda; Claudia Brodskyn; Aldina Barral; Manoel Barral-Netto; Manuel Soto; Camila I de Oliveira
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

7.  Towards a more precise serological diagnosis of human tegumentary leishmaniasis using Leishmania recombinant proteins.

Authors:  Ana Paula Souza; Manuel Soto; Jackson M L Costa; Viviane S Boaventura; Camila I de Oliveira; Juqueline R Cristal; Manoel Barral-Netto; Aldina Barral
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.